These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31941438)

  • 61. Feedback-Based Learning of Timing in Attention-Deficit/Hyperactivity Disorder and Neurofibromatosis Type 1.
    Prochnow A; Bluschke A; Novotna B; von der Hagen M; Beste C
    J Int Neuropsychol Soc; 2022 Jan; 28(1):12-21. PubMed ID: 33573707
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder.
    Shafrin J; Shrestha A; Chandra A; Erder MH; Sikirica V
    Health Econ; 2017 Nov; 26(11):1459-1466. PubMed ID: 27620206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
    Haas-Lude K; Heimgärtner M; Winter S; Mautner VF; Krägeloh-Mann I; Lidzba K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):164-169. PubMed ID: 29111114
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Using a Virtual Classroom environment to describe the attention deficits profile of children with Neurofibromatosis type 1.
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Rizzo AS; Josman N
    Res Dev Disabil; 2011; 32(6):2608-13. PubMed ID: 21757320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delay discounting and response disinhibition under acute experimental stress in women with borderline personality disorder and adult attention deficit hyperactivity disorder.
    Krause-Utz A; Cackowski S; Daffner S; Sobanski E; Plichta MM; Bohus M; Ende G; Schmahl C
    Psychol Med; 2016 Nov; 46(15):3137-3149. PubMed ID: 27572473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Waiting impulsivity: a distinctive feature of ADHD neuropsychology?
    Van Dessel J; Morsink S; Van der Oord S; Lemiere J; Moerkerke M; Grandelis M; Sonuga-Barke E; Danckaerts M
    Child Neuropsychol; 2019 Jan; 25(1):122-129. PubMed ID: 29490561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [α2-Adrenergic agonists, and drugs for ADHD].
    Clement HW; Schulz E
    Pharm Unserer Zeit; 2011 Nov; 40(6):503-9. PubMed ID: 22028136
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
    Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
    Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.
    Schippers MC; Schetters D; De Vries TJ; Pattij T
    Psychopharmacology (Berl); 2016 Jul; 233(14):2775-85. PubMed ID: 27251129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
    Sayer GR; McGough JJ; Levitt J; Cowen J; Sturm A; Castelo E; McCracken JT
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):882-888. PubMed ID: 27483130
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E; Fogler JM; Hammerness PG
    JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preference for Smaller Sooner Over Larger Later Rewards in ADHD: Contribution of Delay Duration and Paradigm Type.
    Yu X; Sonuga-Barke E; Liu X
    J Atten Disord; 2018 Aug; 22(10):984-993. PubMed ID: 25672671
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G; Newcorn JH
    Pediatr Clin North Am; 2011 Feb; 58(1):99-120, xi. PubMed ID: 21281851
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se.
    Lion-François L; Herbillon V; Peyric E; Mercier C; Gérard D; Ginhoux T; Coutinho V; Kemlin I; Kassai B; Desportes V; Michael GA
    J Atten Disord; 2020 Nov; 24(13):1807-1823. PubMed ID: 28587546
    [No Abstract]   [Full Text] [Related]  

  • 79. Impulsivity in cocaine-dependent individuals with and without attention-deficit/hyperactivity disorder.
    Stevens L; Roeyers H; Dom G; Joos L; Vanderplasschen W
    Eur Addict Res; 2015; 21(3):131-43. PubMed ID: 25675959
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.